An Adjuvanted Inactivated SARS-CoV-2 Microparticulate Vaccine Delivered Using Microneedles Induces a Robust Immune Response in Vaccinated Mice
SARS-CoV-2, the causal agent of COVID-19, is a contagious respiratory virus that frequently mutates, giving rise to variant strains and leading to reduced vaccine efficacy against the variants. Frequent vaccination against the emerging variants may be necessary; thus, an efficient vaccination system...
Saved in:
Main Authors: | Sharon Vijayanand (Author), Smital Patil (Author), Ipshita Menon (Author), Keegan Braz Gomes (Author), Akanksha Kale (Author), Priyal Bagwe (Author), Mohammad N. Uddin (Author), Susu M. Zughaier (Author), Martin J. D'Souza (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adjuvanted-SARS-CoV-2 Spike Protein-Based Microparticulate Vaccine Delivered by Dissolving Microneedles Induces Humoral, Mucosal, and Cellular Immune Responses in Mice
by: Smital Patil, et al.
Published: (2023) -
Enhanced Immunogenicity of Adjuvanted Microparticulate HPV16 Vaccines Administered via the Transdermal Route
by: Trinh Phuong Vo, et al.
Published: (2022) -
Potential of DPD ((S)-4,5-dihydroxy-2,3-pentanedione) Analogs in Microparticulate Formulation as Vaccine Adjuvants
by: Devyani Joshi, et al.
Published: (2024) -
Analysis of novel meningococcal vaccine formulations
by: Susu M. Zughaier
Published: (2017) -
Immunogenicity and safety of inactivated Influenza Split-Virion vaccine administered via a Transdermal Microneedle System
by: Mahmoud Ameri, et al.
Published: (2021)